Related Experiment Videos
Metabolic Bone Disease in Inflammatory Bowel Disease
1Inflammatory Bowel Disease Center, Division of Gastroenterology and Hepatology, Northwestern University Medical School, 676 North St. Clair Street, Suite 880, Chicago, IL 60611, USA. a-buchman@northwestern.edu
Current Treatment Options in Gastroenterology
|May 11, 2002
Summary
This study recommends lifestyle and medical interventions for bone health, including calcium, vitamin D, and exercise. Pharmacological treatments like alendronate and estrogen therapy are advised for osteopenia and postmenopausal women, respectively.
Area of Science:
- Endocrinology
- Geriatrics
- Nutritional Science
Background:
- Osteopenia and osteoporosis are significant public health concerns, particularly in aging populations.
- Lifestyle factors and certain medications can negatively impact bone density.
- Early detection and intervention are crucial for managing bone health.
Purpose of the Study:
- To outline evidence-based recommendations for the prevention and management of osteopenia.
- To provide guidance on lifestyle modifications and pharmacological interventions for improving bone mineral density.
- To emphasize the importance of regular monitoring and personalized treatment strategies.
Main Methods:
- Review of current literature and clinical guidelines on bone health management.
- Analysis of the efficacy of various interventions, including nutritional supplements, exercise, and pharmacotherapy.
- Synthesis of recommendations for clinical practice.
Main Results:
- Oral calcium (1000 mg/day) and vitamin D supplementation are recommended, with correction of deficiencies.
- Regular exercise and moderation of ethanol and protein intake are advised.
- Pharmacological treatments such as alendronate or risedronate are indicated for osteopenia.
- Estrogen replacement therapy is recommended for postmenopausal women without contraindications.
- Limiting short-term use of corticosteroids, cyclosporin, tacrolimus, and methotrexate is advised.
Conclusions:
- A multi-faceted approach combining lifestyle modifications, nutritional support, and targeted pharmacotherapy is effective for managing osteopenia.
- Regular bone density monitoring is essential for assessing treatment response and adjusting management strategies.
- Personalized treatment plans considering individual risk factors and patient characteristics are key to optimizing bone health outcomes.